Nearly a million people in China have taken an experimental coronavirus vaccine through the country's emergency use program as of Wednesday, according to vaccine developer China National Pharmaceutical Group .
China initiated the emergency use program in July. The program so far includes three vaccine candidates for essential workers and high-risk individuals, although clinical studies have not yet proved the vaccines' safety and efficacy, according toTwo vaccine candidates are developed by Sinopharm's subsidiary China National Biotec Group , and the third is developed by Sinovac Biotech. All three vaccines have been used for China's emergency program.
FILES-CHINA-HEALTH-VIRUS This file photo taken on September 24, 2020 shows a staff member working during a media tour of a new factory built to produce a Covid-19 coronavirus vaccine at Sinovac, one of 11 Chinese companies approved to carry out clinical trials of potential coronavirus vaccines, in Beijing. As of November 19, nearly a million people in China have taken an experimental coronavirus vaccine through the country’s emergency use program.